PARTICIPANTS in a £1 million clinical trial into the effects of cannabis on multiple sclerosis sufferers have been given their first dose of the drug. Twenty recruits have begun the tests at Derriford Hospital, Plymouth, as part of a three-year study to see if cannabis helps to relieve the symptoms of multiple sclerosis.
Until now, smaller-scale studies have used chemical components of cannabis, but this is the first time the drug itself has been given to patients. Of the 20 MS sufferers, a third have been given capsules containing cannabis oil, a third are taking tetra hydro cannabinol, believed to be one of the most active ingredients in cannabis, and the rest are being given a placebo.
9 December 2000: Cannabis spray eases pain for MS patients
of Telegraph Group Limited 2000.